Lewes, DE -- (SBWire) -- 07/12/2013 --LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: OncoSec Medical Inc (OTCMKTS:ONCS), ScripsAmerica, Inc. (OTCBB:SCRC), Primco Management Inc (OTCBB:PMCM), Titan Pharmaceuticals, Inc. (OTCBB:TTNP)

OncoSec Medical Inc (OTCMKTS:ONCS) recently, trading on 1.49 million shares, at the price of $0.282. The stock changed hands in a range of $0.28to $0.30up till now, bringing its market capitalization at about $24.93 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.17 and was moved to the maximum level of $0.49. OncoSec Medical Incorporated designs, develops, and commercializes novel cancer therapeutic products in the United States. Its products combine proprietary electroporation delivery technology with a chemotherapeutic or novel DNA-based immunotherapeutics, known as OMS ElectroOncology.

Can Investors Bet on ONCS after this News update? Find out in this Research Report

ScripsAmerica, Inc. (OTCBB:SCRC) declined -4.12% recently, in the current trading session, at $0.930 with a total volume of 447,437 shares. The stock, on average, trades on a volume of 408,504 shares. It floated in a range of $0.86 to $0.98. Its market capitalization now moved to about $52.46 million. In the past 52 weeks, the share price has not declined below $0.11 or above $1.05. ScripsAmerica, Inc. engages in the distribution of pharmaceutical products in the United States. It delivers pharmaceutical products, including pain, arthritis, prenatal, urinary, and hormonal replacement drugs to a range of customers across the health care industry, including physician offices, retail pharmacies, long-term care sites, hospitals, and Government and home care agencies.

Will SCRC Get Buyers Even After The Recent Rally? Find Out Here

Primco Management Inc (OTCBB:PMCM) added 261.11% and was moving within a range of $0.0017-$0.0073, its current trading price is $0.0065. The stock is moving up till now with a total volume of 125.94 million shares, versus an average volume of 9.86 million shares. The share price hit its 52-week low of $0.0012 and $0.25 was the best price. Primco Management Inc., a development stage company, focuses on providing real estate management services. It intends to provide real estate management services to a range of properties, including class A office space, industrial, manufacturing, and warehousing facilities, as well as data centers and retail outlets for real estate users.

What was the Moving Force behind PMCM on Bullish Run? Read This Research Report

Titan Pharmaceuticals, Inc. (OTCBB:TTNP) declined -8.22% in its current trading activity, bringing its market capitalization around $51.62 million. The share price, after opening at $0.69, hit a high of $0.69 and hovered above $0.54, while its recent trading price was $0.631. The total number of shares changed hands during the current session up till now was 434,419 shares, as compared to average trading volume of 307,033 shares. Titan Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing proprietary therapeutics for the treatment of serious medical disorders in the United States. The company offers Fanapt (iloperidone), an atypical antipsychotic for the treatment of schizophrenia.

Why Should Investors Buy TTNP After the Recent Fall? Just Go Here and Find Out

About LeadingStockAlerts:
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

Disclaimer
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/